miR-202 was reported to be a direct downstream target of MALAT1 in different types of tumors including NSCLC [49], osteosarcomas [72], gastric [23,24,92], and cervix carcinoma [53], where a negative correlation was found between the expressions of MALAT1 and miR-202. This evidence concerns the gene MALAT1 and osteosarcoma.